Beyond Barriers


our approach

who we are

Beyond Barriers Therapeutics is developing a novel product to treat inflammation and cell death following traumatic brain injury (TBI).  Building upon promising research from the National Institutes of Health, our product uses a unique mechanism to deliver therapeutic drugs to the brain.     


Because of a lack of specific therapies for TBI, patients receive care consisting mainly of passive monitoring and a "wait and see" approach.  We are developing a treatment that would actively help reduce secondary damage to neural tissue following injury.

every 13 seconds someone in America suffers a brain injury.

Opening new pathways for tomorrow's clinical breakthroughs